A detailed history of Jpmorgan Chase & CO transactions in Akili, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 58 shares of AKLI stock, worth $24. This represents 0.0% of its overall portfolio holdings.

Number of Shares
58
Previous 67 13.43%
Holding current value
$24
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$0.21 - $0.45 $1 - $4
-9 Reduced 13.43%
58 $0
Q1 2024

May 10, 2024

BUY
$0.22 - $0.48 $6 - $13
29 Added 76.32%
67 $0
Q4 2023

Feb 12, 2024

BUY
$0.36 - $0.52 $3 - $5
10 Added 35.71%
38 $0
Q3 2023

Nov 14, 2023

BUY
$0.54 - $1.21 $15 - $33
28 New
28 $0

Others Institutions Holding AKLI

About Akili, Inc.


  • Ticker AKLI
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 85,395,200
  • Market Cap $36.7M
More about AKLI
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.